Belldegrun AS - Search Results

1

Using protein expressions to predict survival in clear cell renal carcinoma.

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS. Kim HL, et al. Among authors: belldegrun as. Clin Cancer Res. 2004 Aug 15;10(16):5464-71. doi: 10.1158/1078-0432.CCR-04-0488. Clin Cancer Res. 2004. PMID: 15328185

2

Collecting duct renal cell carcinoma: clinical study of a rare tumor.

Chao D, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS. Chao D, et al. Among authors: belldegrun as. J Urol. 2002 Jan;167(1):71-4. doi: 10.1016/s0022-5347(05)65385-2. J Urol. 2002. PMID: 11743278

3

Mathematical model to predict individual survival for patients with renal cell carcinoma.

Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Clin Oncol. 2002 Mar 1;20(5):1368-74. doi: 10.1200/JCO.2002.20.5.1368. J Clin Oncol. 2002. PMID: 11870181

4

Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS. Janzen N, et al. Among authors: belldegrun as. Curr Urol Rep. 2002 Feb;3(1):13-20. doi: 10.1007/s11934-002-0005-8. Curr Urol Rep. 2002. PMID: 12084214 Review.

5

Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype.

Zisman A, Chao DH, Pantuck AJ, Kim HJ, Wieder JA, Figlin RA, Said JW, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Urol. 2002 Sep;168(3):950-5. doi: 10.1016/S0022-5347(05)64549-1. J Urol. 2002. PMID: 12187197

6

Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?

Zisman A, Pantuck AJ, Chao DH, Wieder JA, Dorey F, Said JW, Kernion JB, Figlin R, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Urol. 2002 Sep;168(3):962-7. doi: 10.1016/S0022-5347(05)64552-1. J Urol. 2002. PMID: 12187200

7

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.

Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A. Rao J, et al. Cancer. 2002 Sep 15;95(6):1247-57. doi: 10.1002/cncr.10823. Cancer. 2002. PMID: 12216092 Free article.

8

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Clin Oncol. 2002 Dec 1;20(23):4559-66. doi: 10.1200/JCO.2002.05.111. J Clin Oncol. 2002. PMID: 12454113

9

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS. Bui MH, et al. Among authors: belldegrun as. Clin Cancer Res. 2003 Feb;9(2):802-11. Clin Cancer Res. 2003. PMID: 12576453

10

Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.

Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Urol. 2003 Mar;169(3):909-16. doi: 10.1097/01.ju.0000045706.35470.1e. J Urol. 2003. PMID: 12576811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters